Get the Stockscreener App
3.34
3.41%
0.11
After Hours:
3.38
0.04
+1.20%
Organogenesis Holdings Inc stock is traded at $3.34, with a volume of 667.69K.
It is up +3.41% in the last 24 hours and up +15.17% over the past month.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
See More
Previous Close:
$3.23
Open:
$3.19
24h Volume:
667.69K
Relative Volume:
0.48
Market Cap:
$440.18M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
93.56
EPS:
0.0357
Net Cash Flow:
$6.55M
1W Performance:
+3.09%
1M Performance:
+15.17%
6M Performance:
+5.03%
1Y Performance:
+33.60%
1-Day Range:
$3.13
$3.34
1-Week Range:
$3.08
$3.36
52-Week Range:
$2.28
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Name
Organogenesis Holdings Inc
Sector
Phone
781-575-0775
Address
85 DAN ROAD, CANTON, MA
Compare ORGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
3.34 | 440.18M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
RGC
Regencell Bioscience Holdings Ltd
|
23.70 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
157.34 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.49 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.97 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Lake Street | Buy |
| Feb-07-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-15-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-24-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-10-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-10-20 | Initiated | SVB Leerink | Outperform |
| Aug-26-19 | Resumed | Credit Suisse | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
| Apr-17-19 | Initiated | Oppenheimer | Outperform |
| Apr-11-19 | Initiated | SunTrust | Buy |
View All
Organogenesis Holdings Inc Stock (ORGO) Latest News
Assenagon Asset Management S.A. Lowers Stock Holdings in Organogenesis (NASDAQ:ORGO) - Defense World
Organogenesis (NASDAQ:ORGO) Shares Acquired by Wealth Enhancement Advisory Services LLC - Defense World
Merit Financial Group LLC Makes New Investment in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings leases 123,000 s/f at The Davis Cos.’ 100 Technology Way - NEREJ
Analysts Set Expectations for Organogenesis FY2026 Earnings - Defense World
Organogenesis Holdings: ReNu And New LCD Offer A Rebound Scenario - Seeking Alpha
Millennium Management LLC Raises Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Ameriprise Financial Inc. Sells 61,072 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Insider Buying: Lori Freedman Acquires Shares in Organogenesis H - GuruFocus
3 Growth Companies With High Insider Ownership Achieving 101% Earnings Growth - simplywall.st
Kalkine: Squarepoint Expands Stake in Organogenesis (NASDAQ:ORGO), a Healthcare Peer to FTSE 100 Companies - Kalkine Media
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Mackenzie Financial Corp - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Squarepoint Ops LLC - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stake Cut by Nuveen Asset Management LLC - Defense World
Two Sigma Investments LP Has $1.22 Million Stake in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Position Increased by Bank of America Corp DE - Defense World
Organogenesis: Build On Weakness For Big ReNu Knee OA Payday (NASDAQ:ORGO) - Seeking Alpha
ProShare Advisors LLC Purchases 6,689 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Northern Trust Corp Raises Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis signs full-building lease for biomanufacturing facility in Smithfield - Providence Business News
Organogenesis Inks Full-Building Lease with Davis in RI - Connect CRE
Price T Rowe Associates Inc. MD Sells 24,540 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Expands Footprint with Full-Building Lease at Davis Biomanufacturing Facility in Smithfield, RI - Boston Real Estate Times
Dimensional Fund Advisors LP Increases Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Barclays PLC Grows Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Wells Fargo & Company MN - Defense World
Organogenesis Holdings First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2025 Earnings Call Transcript - Insider Monkey
CLASS ACTION REMINDER: Kessler Topaz Meltzer & Check, LLP Reminds Organogenesis Holdings Inc. (ORGO) Shareholders of Securities Fraud Class Action Lawsuit - ACCESS Newswire
Organogenesis (NASDAQ:ORGO) Shares Gap Down After Earnings Miss - Defense World
Organogenesis Faces Challenges but Sees Growth Potential - TipRanks
Organogenesis: Q1 Earnings Snapshot - New Haven Register
38,341 Shares in Organogenesis Holdings Inc. (NASDAQ:ORGO) Bought by Mariner LLC - Defense World
Organogenesis Holdings Inc (ORGO) Q1 2025 Earnings Call Highlights: Navigating Market ... By GuruFocus - Investing.com Canada
Earnings call transcript: Organogenesis Q1 2025 sees revenue drop, stock plummets - Investing.com
Organogenesis Reports Q1 2025 Financial Results - TipRanks
Burn Care Market Worth $3.35 Billion By 2030 With 5.6% CAGR - Barchart.com
ORGO Reveals FY25 Adjusted EBITDA Outlook and ReNu Development Progress | ORGO Stock News - GuruFocus
Organogenesis Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results - The Manila Times
Daily Market Movement: Organogenesis Holdings Inc (ORGO) Sees a -2.26 Decrease, Closing at 5.20 - DWinneX
Organogenesis Holdings Inc (ORGO) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Organogenesis (ORGO) Expected to Announce Earnings on Thursday - Defense World
Organogenesis Holdings Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Organogenesis Holdings Inc. (NASDAQ:ORGO) Stock Catapults 36% Though Its Price And Business Still Lag The Industry - simplywall.st
ORGO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
How does Organogenesis Holdings Inc (ORGO) change from a tortoise to a hare? - Sete News
Wound Care Biologics Market to Witness Massive Growth by 2032 | - openPR.com
Organogenesis Holdings Inc (NASDAQ: ORGO) Could Slash -20.97% Soon - Stocksregister
Organogenesis Holdings Inc (ORGO) stock on the rise: An overview - uspostnews.com
Organogenesis (ORGO) Projected to Post Quarterly Earnings on Thursday - The AM Reporter
Organogenesis Holdings Inc Stock (ORGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Organogenesis Holdings Inc Stock (ORGO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 04 '25 |
Buy |
2.82 |
100,863 |
284,716 |
695,058 |
| Freedman Lori | Chief Admin. and Legal Officer |
Jun 06 '25 |
Buy |
2.99 |
9,022 |
26,949 |
846,459 |
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):